Summary and conclusions
The rapid progress made over the last 10 years in the identification of individual autoantigens and in the localization of the epitopes involved, has resulted in a parallel reduction in the complexity of the antigen required for the detection of autoantibodies. The ability to use synthetic peptides as antigens is a remarkable culmination of this process considering that many antigenic particles contain multiple proteins (eg. Sm consist of 8 or more individual proteins).
Despite the fact that patients with SLE have a polyclonal hypergammaglobulinemia, excellent correlations between ELISAs utilizing the P2 or SmB/B′ synthetic peptides, ELISAs utilizing r proteins and immunoblotting were obtained [28, 38, 50]. However, false positive/non-specific binding to a P2-BSA-glutaraldehyde conjugate has been observed with serum from old MRL/lpr mice (unpublished observations). In addition, some of the results obtained in human autoimmune diseases suggest that non-specific binding may be problematic in some instances. It is difficult, at present, to know whether the higher frequencies of detection of autoantibodies to certain synthetic peptide antigens reflect increased sensitivity or decreased specificity.
Synthetic peptide antigens have beeen used to detect autoantibodies in both organ specific and multisystem autoimmune diseases. In only a small number of cases have these reagents been rigorously tested for sensitivity and specificity. Despite this, synthetic peptides have been shown to be valuable for detection and quantification of autoantibodies in certain clinical situations. Undoubtedly, further progress in epitope mapping of autoantigens coupled with technological advances in protein synthesis and improved prediction of protein structure will lead to a large number of synthetic peptide antigens for research and clinical applications. It is unlikely that short synthetic peptides will substitute for native proteins in all instances since some autoantibodies show a striking preference for conformational epitopes.
Similar content being viewed by others
Abbreviations
- r:
-
recombinant
- SLE:
-
systemic lupus erythematosus
References
Gharavi AE, Chu JL & Elkon KB (1988) Arthritis Rheum. 31: 1337–1345
Tan EM, Chan EKL, Sullivan KF & Rubin RL (1988) Clin. Immunol. Immunopathol. 47: 121–141
Bonfa E, Llovet R & Elkon KB (1988) J. Immunol. 140: 2231–2236
Benjamin DC, Berzofsky JA, East IJ, Gurd FRN, Hannum C, et al. (1984) Annu. Rev. Immunol. 2: 67–101.
Laver WG, Air GM, Webster RG & Smith-Gill SJ (1990) Cell 61: 553–556
Leach SJ (1983) Biopolymers 22: 425–431
Niman HL, Houghten RA, Walker LE, Reisfeld RA, Wilson IA, Hogle JM & Lerner RA (1983) Proc. Natl. Acad. Sci. USA 80: 4949–4953
Jemmerson R (1987) Proc. Natl. Acad. Sci. USA 84: 9180–9184
Trifilieff E, Dubs MC, vanRegenmortel MHV (1991) Molec. Immunol. 28: 889–896
Kent SBH, (1988) Annu. Rev. Biochem. 57: 957–989
Huang NC, Sayer JM & Kang AK (1990) J. Immunol. Methods 129: 77–88
Pelleguer JL, Westhof E & vanRegenmortel MHV (1991) Methods Enzymol. 203: 176–201
Thornton JM (1988) Nature 335: 10–11
Bonfa E, Marshak-Rothstein A, Weissbach H, Brot N & Elkon KB (1988) J. Immunol. 140: 3434–3437
Portanova JP, Cheronis JC, Blodgett JK & Kotzin BL (1991) J. Immunol. 146: 4633–4639
St. Clair EW, Kenan D, Burch JA, Keene JD & Pisetsky DS (1991) J. Immunol. 146: 1885–1892
Lindstrom J (1985) Annu. Rev. Immunol. 3: 109–131
Tzartos SJ, Kokla A, Walgrave SL & Conti-Tronconi BM (1988) Proc. Natl. Acad. Sci. USA 85: 2899–2903
Brocke S, Brautbar C, Steinman L, Abramsky O, Rothbard J, Neumann D, Fuchs S & Mozes E (1988) J. Clin. Invest. 82: 1894–1900
Ohta M, Ohta K, Itoh N, Nishitani H, Hara H & Hayashi K (1990) Neurology 40: 1776–1778
Wadsworth HL, Chazenbalk GD, Nagayama Y, Russo D & Raporport B (1990) Science 249: 1423–1425
Murakami M & Mori M (1990) Biochem. Biophys. Res. Comm. 171: 512–518
Mori T, Sugawa H, Piraphatdist T, Inove D, Enomoto T & Imura H (1991) Biochem. Biophys. Res. Comm. 178: 165–172
Van deWater J, Gershwin ME, Leung P, Ansari A & Coppel RL (1988) J. Exp. Med. 167: 1791–1799
Elkon KB, Skelly S, Parnassa A, Moller W, Weissbach H & Brot N (1986) Proc. Natl. Acad. Sci. USA 83: 7419–7423
Elkon K, Parnassa AP & Foster CL (1985) J. Exp. Med. 162: 459–471
Francoeur AM, Peebles CL, Heckman KJ, Lee JC & Tan EM (1985) J. Immunol. 135: 2378–2384
Bonfa E, Golombek SJ, Kaufman L, Skelly S, Weissbach H, Brot N & Elkon KB (1987) N. Engl. J. Med. 317: 265–271
Schneebaum AB, Singleton JD, West SG, Blodgett JK, Allen LG, Cheronis JC & Kotzin BL (1991) Am. J. Med. 90: 54–62
vanDam AP, Derksen RHWM, Gmelig Meyling F et al. (1990) Ann. Rheum. Dis. 49: 779–782
vanDam AP, Nossent H, deJong J, Meilof J, Ter Borg E-J, Swaak T & Smeenk R (1991) J. Rheumatol. 18: 1026–1034
Billings PB & Hoch SO (1983) J. Immunol. 131: 347–351
Habets WJ, deRooij DJ, Hoet MH, van dePutte LBA & vanVenrooij WJ (1985) Clin. Exp. Immunol. 59: 457–466
Elkon KB & Jankowski PW (1985) J. Immunol. 134: 3819–3824
Elkon KB, Hines JJ, Chu JL & Parnassa AP (1990) J. Immunol. 145: 636–643
Rokeach LA, Jannatipour M & Hoch SA (1990) J. Immunol. 144: 1015–1022
Habets WJ, Sillekens PTG, Hoet MH, McAllister G, Lerner MR & vanVenrooij WJ (1989) Proc. Natl. Acad. Sci. USA 86: 4674–4678
Hines JJ, Danho W & Elkon KB (1991) Arthritis Rheum. 34: 572–579
Barakat S, Briand J-P, Weber J-C, vanRegenmortel MHV & Muller S (1990) Clin. Exp. Immunol. 81: 256–262
Muller S, Barakat S, Watts R, Joubaud P & Isenberg DL (1990) Clin. Exp. Rheumatol. 8: 445–453
Barakat S, Briand J-P, Abauf N, vanRegenmortel MHV & Muller S (1991) Clin. Exp. Immunol. 86: 71–78
Lieu T-S, Newkirk MM, Capra JD & Sontheimer RD (1988) J. Clin. Invest. 82: 96–101
McCauliffe DP, Zappi E, Lieu T-S, Michalak M, Sontheimer RD & Capra JD (1990) J. Clin. Invest. 86: 332–335
Rokeach LA, Haselby JA, Meilof JF, Smeenk RJT, Unnasch TR, Greene BM & Hoch SO (1991) J. Immunol. 147: 3031–3039
Scofield RH, Dickey WD, Jackson KW, James JA & Harley JB (1991) J. Clin. Immunol. 11: 378–388
Bini P, Chu JL, Okolo C, & Elkon KB (1990) J. Clin. Invest. 85: 325–333
Muller S, Bonnier D, Thiry M & vanRegenmortel MHV (1989) Int. Arch. Allergy Appl. Immunol. (1989) 89: 288–296
Bernstein RM, Hobbs RN & Lea DJ (1985) Arthritis Rheum. 28: 285–293
Tuaillon N, Muller S, Pasquali J-L, Bordigoni P, Youinou P & vanRegenmortel MHV (1990) Int. Arch. Allergy Appl Immunol. 91: 297–305
Magsaam J, Gharavi AE, Parnassa AP, Weissbach H, Brot N & Elkon KB (1989) Clin. Exp. Immunol. 76: 165–171
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Elkon, K.B. Use of synthetic peptides for the detection and quantification of autoantibodies. Mol Biol Rep 16, 207–212 (1992). https://doi.org/10.1007/BF00464709
Issue Date:
DOI: https://doi.org/10.1007/BF00464709